Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2580)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2024 (publication date) through Jul 28, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wishahi M. Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept. World J Hepatol 2024; 16(4): 490-493 [PMID: 38689741 DOI: 10.4254/wjh.v16.i4.490] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i4/490.htm |
| Number | Citing Articles |
| 1 |
Matteo Ferro, Felice Crocetto, Letizia Maria Ippolita Jannello, Roberto Contieri, Ugo Giovanni Falagario, Alessandro Veccia, Michele Marchioni, Sabin Octavian Tataru, Biagio Barone, Giuseppe Fallara, Marco Tozzi, Francesco Chierigo, Martina Maggi, Roberto Bianchi, Francesco Pellegrino, Bernardo Maria Cesare Rocco, Vartolomei Mihai Dorin, Daniela Terracciano. Emerging Biomarkers in Bladder Cancer: Translating Molecular Advances into Precision Oncology. Critical Reviews in Oncology/Hematology 2025; : 104862 doi: 10.1016/j.critrevonc.2025.104862
|